This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Synacthen test

Authoring team

The synacthen test is used to test adrenal reserve. Synacthen is tetracosactrin, the first 24 amino acids of ACTH.

Short synacthen test:

  • take a basal sample for cortisol
  • give 250 microgramme Synacthen i.v. or i.m.
  • sample for cortisol are taken at 30 mins and 60 mins

In healthy individuals, the basal plasma cortisol should exceed 170 nmol per litre and rise to at least 580 nmol per litre. The hypoadrenal patient is unable to raise their serum cortisol in response to synacthen.

A depot synacthen test may be performed if the short procedure is equivocal and Addison's disease is suspected:

  • basal plasma cortisol is measured
  • 1 mg of synacthen is given intramuscularly
  • samples for cortisol are taken at 1, 4, 8, and 24 hours

Plasma cortisol fails to exceed 580 nmol per litre in Addisons disease but in secondary hypoadrenalism, a delayed but normal cortisol response may be observed.


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.